Chris Tanski, PharmD
Chris Tanski, PharmD
Chris Tanski received his PharmD from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences and is now working as a clinical staff pharmacist for Pinnacle Health in Harrisburg, Pennsylvania. He entered the field of hospital pharmacy directly from school, and he was one of the first to pilot a decentralized pharmacist role in the hospital. His other notable work contributions include working on palliative projects and transition of care for COPD patients. Chris was an editor and contributor to a film theory blog, a sketch comedy writer throughout pharmacy school, and he has a significant amount of experience writing drug information papers on neurology and infectious disease topics for both school and work.
Articles
Aug 14, 2017 @01:53 AM
Could Montelukast Be a Key to Managing GI Side Effects of Tecfidera?

May 30, 2017 @11:50 AM
Ocrevus is the first medication approved for primary-progressive MS. Here's what you should know.

May 10, 2017 @03:26 AM
What are the best practice considerations for managing Parkinson's Psychosis?

May 8, 2017 @02:07 AM
The first new FDA approval for ALS in 22 years, here's what you should know.

Jun 2, 2016 @12:29 PM
The FDA has issued new guidance for the use of the first-line diabetes drug metformin in patients with renal impairment.